+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Praziquantel"

Anthelmintic Drugs Market Report 2025 - Product Thumbnail Image

Anthelmintic Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Antiparasitic Drugs Market Report 2025 - Product Thumbnail Image

Antiparasitic Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Schistosomiasis - Pipeline Insight, 2024 - Product Thumbnail Image

Schistosomiasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Pregnancy and Anti-Infective Agents - Product Thumbnail Image

Pregnancy and Anti-Infective Agents

  • Book
  • November 2020
From
Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Thumbnail Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • July 2023
  • 1568 Pages
  • 14 Results (Page 1 of 1)
Loading Indicator

Praziquantel is a medication used to treat a variety of parasitic infections, including schistosomiasis, tapeworms, and flukes. It is a member of the anthelmintic class of drugs, which are used to treat parasitic worm infections. Praziquantel is the most widely used anthelmintic drug in the world, and is the drug of choice for treating schistosomiasis. It is also used to treat other parasitic infections, such as tapeworms and flukes. Praziquantel is available in both oral and injectable forms, and is generally well tolerated with few side effects. The market for praziquantel is driven by the prevalence of parasitic infections, particularly in developing countries. The World Health Organization (WHO) estimates that over 1 billion people are infected with parasitic worms, and praziquantel is the drug of choice for treating these infections. The market is also driven by the increasing prevalence of drug-resistant parasites, which require more effective treatments. The praziquantel market is highly competitive, with several major players. These include Merck & Co., Bayer AG, Sanofi, GlaxoSmithKline, and Pfizer. Other companies in the market include Novartis, Johnson & Johnson, and Teva Pharmaceuticals. Show Less Read more